已发表论文

预测结肠直肠癌分子表型的线型图

 

Authors Yu Z, Yu H, Zou Q, Huang Z, Wang X, Tang G, Bai L, Zhou C, Zhuang Z, Xie Y, Wang H, Xu G, Chen Z, Fu X, Huang M, Luo Y

Received 13 October 2019

Accepted for publication 24 December 2019

Published 13 January 2020 Volume 2020:13 Pages 309—321

DOI https://doi.org/10.2147/OTT.S234495

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Federico Perche

Background: Colorectal cancer (CRC) patients with different molecular phenotypes, including microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and somatic mutations in BRAF  and KRAS  gene, vary in treatment response and prognosis. However, molecular phenotyping under adequate quality control in a community-based setting may be difficult. We aimed to build the nomograms based on easily accessible clinicopathological characteristics to predict molecular phenotypes.
Methods: Three hundred and six patients with pathologically confirmed stage I-IV CRC were included in the cohort. The assays for MSI, CIMP, and mutations in BRAF  and KRAS  gene were performed using resected tumor samples. The candidate predictors were identified from clinicopathological variables using multivariate Logistic regression analyses to construct the nomograms that could predict each molecular phenotype.
Results: The incidences of MSI, CIMP, BRAF  mutation and KRAS  mutation were 25.3% (72/285), 2.5% (7/270), 3.4% (10/293), and 34.8% (96/276) respectively. In the multivariate Logistic analysis, poor differentiation and high neutrophil/lymphocyte ratio (NLR) were independently associated with MSI; poor differentiation, high NLR and high carcinoembryonic antigen/tumor size ratio (CSR) were independently associated with CIMP; poor differentiation, lymphovascular invasion and high CSR were independently associated with BRAF  mutation; poor differentiation, proximal tumor, mucinous tumor and high NLR were independently associated with KRAS  mutation. Four nomograms for MSI, CIMP, BRAF  mutation and KRAS  mutation were developed based on these independent predictors, the C-indexes of which were 61.22% (95% CI: 60.28– 62.16%), 95.57% (95% CI: 95.20– 95.94%), 83.56% (95% CI: 81.54– 85.58%), and 69.12% (95% CI: 68.30– 69.94%) respectively.
Conclusion: We established four nomograms using easily accessible variables that could well predict the presence of MSI, CIMP, BRAF  mutation and KRAS  mutation in CRC patients.
Keywords: colorectal cancer, microsatellite instability, CpG island methylator phenotype, BRAF KRAS , nomogram, prediction of molecular subtypes




Figure 1 Flow diagram for patient disposition and...